StonvexLoading…
StonvexStonvexStonvexCore line items from CGON's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $4.04M | $1.14M | $204.00K |
Operating Income | $-190.77M | $-114.67M | $-55.45M |
Net Income | $-161.00M | $-88.04M | $-48.61M |
EPS (Diluted) | $-2.08 | $-1.41 | $-15.65 |
Total Assets | $791.59M | $754.80M | $199.30M |
Total Liabilities | $38.99M | $21.42M | $14.51M |
Cash & Equivalents | $32.49M | $257.07M | $8.27M |
Free Cash Flow OCF − CapEx | $-132.48M | $-78.95M | Not available |
Shares Outstanding | 80.69M | 76.15M | 5.22M |